13F HOLDINGS REPORT
Velan Capital Investment Management LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000938552-25-000003
Total Value
$97.2M
Positions
49
Other Managers
0
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | HRTX | 6,986,744 | $15.4M | 15.81% |
| 2 | ACELYRIN INC | 00445A100 | 3,366,945 | $8.3M | 8.56% |
| 3 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 185,520 | $8.2M | 8.42% |
| 4 | PROTARA THERAPEUTICS INC | TARA | 1,667,800 | $7.1M | 7.31% |
| 5 | PRAXIS PRECISION MEDICINES I | PRAX | 185,000 | $7.0M | 7.21% |
| 6 | VERONA PHARMA PLC | 925050106 | 95,000 | $6.0M | 6.20% |
| 7 | JASPER THERAPEUTICS INC | JSPRW | 1,188,500 | $5.1M | 5.26% |
| 8 | ZEVRA THERAPEUTICS INC | ZVRA | 665,000 | $5.0M | 5.12% |
| 9 | TOURMALINE BIO INC | 89157D105 | 319,080 | $4.9M | 4.99% |
| 10 | LIQUIDIA CORPORATION | LQDA | 300,000 | $4.4M | 4.55% |
| 11 | INSPIREMD INC | NSPR | 904,029 | $2.4M | 2.50% |
| 12 | SCPHARMACEUTICALS INC | 810648105 | 917,668 | $2.4M | 2.48% |
| 13 | MINERALYS THERAPEUTICS INC | MLYS | 150,600 | $2.4M | 2.46% |
| 14 | TOURMALINE BIO INC | 89157D105 | 136,332 | $2.1M | 2.13% |
| 15 | REPLIMUNE GROUP INC | REPL | 182,083 | $1.8M | 1.83% |
| 16 | EDESA BIOTECH INC | EDSA | 687,500 | $1.7M | 1.73% |
| 17 | INSTIL BIO INC | TIL | 69,000 | $1.2M | 1.23% |
| 18 | REZOLUTE INC | RZLT | 400,000 | $1.2M | 1.19% |
| 19 | ELEDON PHARMACEUTICALS INC | ELDN | 323,973 | $1.1M | 1.13% |
| 20 | PERSPECTIVE THERAPEUTICS INC | CATX | 500,000 | $1.1M | 1.10% |
| 21 | JASPER THERAPEUTICS INC | JSPRW | 245,328 | $1.1M | 1.09% |
| 22 | GERON CORP | GERN | 655,000 | $1.0M | 1.07% |
| 23 | IMMUNOME INC | IMNM | 153,500 | $1.0M | 1.06% |
| 24 | TELA BIO INC | TELA | 747,410 | $911,840 | 0.94% |
| 25 | AVALO THERAPEUTICS INC | AVTX | 111,972 | $896,896 | 0.92% |
| 26 | SUTRO BIOPHARMA INC | STRO | 1,030,000 | $670,118 | 0.69% |
| 27 | UPSTREAM BIO INC | UPB | 107,000 | $654,840 | 0.67% |
| 28 | TENAX THERAPEUTICS INC | TENX | 83,333 | $545,831 | 0.56% |
| 29 | KIORA PHARMACEUTICALS INC | KPHMW | 122,223 | $367,891 | 0.38% |
| 30 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 59,000 | $313,290 | 0.32% |
| 31 | REGULUS THERAPEUTICS INC | 75915K309 | 80,000 | $140,000 | 0.14% |
| 32 | WAVE LIFE SCIENCES LTD | WVE | 13,000 | $105,040 | 0.11% |
| 33 | GOSSAMER BIO INC | GOSS | 75,000 | $82,500 | 0.08% |
| 34 | ERASCA INC | ERAS | 50,000 | $68,500 | 0.07% |
| 35 | ALECTOR INC | ALEC | 55,000 | $67,650 | 0.07% |
| 36 | LARIMAR THERAPEUTICS INC | LRMR | 28,000 | $60,200 | 0.06% |
| 37 | PROQR THRAPEUTICS N V | N71542109 | 45,000 | $59,850 | 0.06% |
| 38 | CONTEXT THERAPEUTICS INC | CNTX | 90,000 | $55,080 | 0.06% |
| 39 | DESIGN THERAPEUTICS INC | DSGN | 14,000 | $54,040 | 0.06% |
| 40 | ACLARIS THERAPEUTICS INC | ACRS | 35,000 | $53,550 | 0.06% |
| 41 | CYTOMX THERAPEUTICS INC | CTMX | 75,000 | $47,685 | 0.05% |
| 42 | TERNS PHARMACEUTICALS INC | TERN | 17,000 | $46,920 | 0.05% |
| 43 | VENTYX BIOSCIENCES INC | 92332V107 | 40,000 | $46,000 | 0.05% |
| 44 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 12,000 | $38,760 | 0.04% |
| 45 | PMV PHARMACEUTICALS INC | PMVP | 35,000 | $38,150 | 0.04% |
| 46 | OVID THERAPEUTICS INC | OVID | 97,000 | $30,254 | 0.03% |
| 47 | KRONOS BIO INC | 50107A104 | 35,000 | $28,875 | 0.03% |
| 48 | NEXTCURE INC | NXTC | 25,000 | $12,008 | 0.01% |
| 49 | ELEVATION ONCOLOGY INC | 28623U101 | 45,000 | $11,660 | 0.01% |